Danaher gives investors reasons to stick around, sending beaten

Danaher shares soared on Tuesday after the supplier of tools and equipment to drugmakers and hospitals provided an upbeat initial forecast for growth next year. After an extended stretch of sluggishness, investors were happy to look past third-quarter results and current-quarter guidance that were solid, not stellar. Revenue for the three months ended Sept. 26 increased 4.5% year over year to $6.05 billion, topping the consensus estimate of $6.01 billion, according to LSEG. On a core basis — which strips out the impact of currency fluctuations to provide a better understanding of actual demand — sales were up 3% versus the year-ago period. Adjusted earnings per share (EPS) totaled $1.89, exceeding the $1.72 estimate, LSEG data showed. On an annual basis, adjusted EPS was up 10.5%. Shares o